45
|
158
|
3rttA |
Human mmp-12 catalytic domain in complex with*(r)-n*-hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-carboxamide |
45
|
158
|
3rtsA |
Human mmp-12 catalytic domain in complex with*n*-hydroxy-2-(2-phenylethylsulfonamido)acetamide |
264
|
665
|
2o3eA |
Crystal structure of engineered neurolysin with thimet oligopeptidase specificity for neurotensin cleavage site. |
47
|
159
|
5labA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor nngh |
50
|
163
|
5h8xA |
Crystal structure of the complex mmp-8/bf471 (catechol inhibitor) |
46
|
169
|
5b5pA |
Crystal structure of the catalytic domain of mmp-13 complexed with 4-oxo-n-(3-(2-(1h-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4-dihydroquinazoline-2-carboxamide |
278
|
696
|
4zr5A |
Soluble rabbit neprilysin in complex with phosphoramidon |
180
|
512
|
5d1sA |
Anthrax toxin lethal factor with hydroxamic acid inhibitor |
170
|
469
|
5d7wA |
Crystal structure of serralysin |
184
|
510
|
5d1tA |
Anthrax toxin lethal factor with hydroxamic acid inhibitor |
46
|
159
|
5d3cA |
Crystal structure of a double mutant catalytic domain of human mmp12 in complex with an hydroxamate analogue of rxp470 |
44
|
159
|
5czmA |
Crystal structure of a mutated catalytic domain of human mmp12 in complex with rxp470 |
167
|
510
|
5d1uA |
Anthrax toxin lethal factor with hydroxamic acid inhibitor |
45
|
159
|
5cxaA |
Crystal structure of the catalytic domain of human mmp12 in complex with a carboxylate inhibitor related to rxp470 |
44
|
159
|
5d2bA |
Crystal structure of a mutated catalytic domain of human mmp12 in complex with an hydroxamate analogue of rxp470 |
49
|
164
|
5cuhA |
Crystal structure mmp-9 complexes with a constrained hydroxamate based inhibitor lt4 |
173
|
511
|
4xm6A |
Anthrax toxin lethal factor with ligand-induced binding pocket |
174
|
511
|
4xm8A |
Anthrax toxin lethal factor with ligand-induced binding pocket |
278
|
696
|
4xbhA |
Soluble rabbit neprilysin |
170
|
513
|
4xm7A |
Anthrax toxin lethal factor with ligand-induced binding pocket |
45
|
158
|
4wzvA |
Crystal structure of a hydroxamate based inhibitor en140 in complex with the mmp-9 catalytic domain |
71
|
216
|
4wk7A |
Crystal structure of human adamts-4 in complex with inhibitor (compound 1, 2-(4-chlorophenoxy)-n-{[(4r)-4-methyl-2,5-dioxoimidazolidin-4-yl]methyl} acetamide) |
45
|
157
|
4xctA |
Crystal structure of a hydroxamate based inhibitor arp101 (en73) in complex with the mmp-9 catalytic domain. |
71
|
220
|
4wkeA |
Crystal structure of human adamts-4 in complex with inhibitor 5-chloro-n-{[(4r)-2,5-dioxo-4-(1,3-thiazol-2-yl)imidazolidin-4-yl]methyl}-1-benzofuran-2-carboxamide (compound 10) |
193
|
511
|
4wf6A |
Anthrax toxin lethal factor with bound small molecule inhibitor mk-31 |
70
|
221
|
4wkiA |
Crystal structure of human adamts-4 in complex with inhibitor 5-chloro-n-{[(4s)-4-(1-methyl-1h-imidazol-2-yl)-2,5-dioxoimidazolidin-4-yl]methyl}-1-benzofuran-2-carboxamide (compound 11) |
60
|
179
|
4r3vA |
Structure of karilysin propeptide and catalytic mmp domain |
50
|
163
|
4qkzA |
X-ray structure of the catalytic domain of mmp-8 with the inhibitor ml115 |
73
|
202
|
4q1lA |
Crystal structure of leucurolysin-a complexed with an endogenous tripeptide (qsw). |
193
|
513
|
4pkqA |
Anthrax toxin lethal factor with bound zinc |
181
|
515
|
4pkvA |
Anthrax toxin lethal factor with bound small molecule inhibitor 16 |
181
|
514
|
4pktA |
Anthrax toxin lethal factor with bound small molecule inhibitor 13 |
178
|
510
|
4pkrA |
Anthrax toxin lethal factor with bound small molecule inhibitor 10 |
177
|
510
|
4pksA |
Anthrax toxin lethal factor with bound small molecule inhibitor 11 |
173
|
511
|
4pkuA |
Anthrax toxin lethal factor with bound small molecule inhibitor 15 |
186
|
511
|
4pkwA |
Anthrax toxin lethal factor with bound small molecule inhibitor gm6001 |
115
|
365
|
4on1A |
Crystal structure of metalloproteinase-ii from bacteroides fragilis |
79
|
258
|
4l6tA |
Gm1 bound form of the ecx ab5 holotoxin |
48
|
166
|
4l19A |
Matrix metalloproteinase-13 complexed with selective inhibitor compound q1 |
78
|
258
|
4l63A |
Apo form of ab5 holotoxin |
87
|
261
|
4l7aA |
Crystal structure of a putative zinc-binding metallo-peptidase (baccac_01431) from bacteroides caccae atcc 43185 at 2.10 a resolution |
55
|
166
|
4in9A |
Structure of karilysin mmp-like catalytic domain in complex with inhibitory tetrapeptide swfp |
244
|
630
|
4iuwA |
Crystal structure of pepo from lactobacillus rhamnosis hn001 (dr20) |
44
|
158
|
4ijoA |
Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases |
169
|
469
|
4i35A |
The crystal structure of serralysin |
72
|
200
|
4j4mA |
Crystal structure of tm-1, a trimeresurus mucrosquamatus venom metalloproteinase |
47
|
164
|
4jijA |
Crystal structure of an inactive mutant of mmp-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate |
45
|
159
|
4ilwD |
Complex of matrix metalloproteinase-10 catalytic domain (mmp-10cd) with tissue inhibitor of metalloproteinases-2 (timp-2) |
46
|
164
|
4jqgA |
Crystal structure of an inactive mutant of mmp-9 catalytic domain in complex with a fluorogenic synthetic peptidic substrate with a fluorine atom. |
49
|
134
|
4hx3A |
Crystal structure of streptomyces caespitosus sermetstatin in complex with s. caespitosus snapalysin |